Cancer stem cells: Characteristics and their potential role for new therapeutic strategies

Onkologie

Volumn 34, Issue 5, 2011, Pages 269-274

  Bohl, Stephan R ^a   Pircher, Andreas ^a   Hilbe, Wolfgang ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

Cancer resistance; Cancer stem cells; CD133; CD44; Hedgehog; Notch; Solid tumours

Indexed keywords

ANTINEOPLASTIC AGENT; BETA SECRETASE INHIBITOR; BIVATUZUMAB; CAMPTOTHECIN; CD133 ANTIGEN; CELL MARKER; CISPLATIN; CYCLOPHOSPHAMIDE; FLUOROURACIL; HERMES ANTIGEN; MERTANSINE; NOTCH RECEPTOR; PACLITAXEL; SALINOMYCIN; SONIC HEDGEHOG PROTEIN; SONIC HEDGEHOG PROTEIN INHIBITOR; UNCLASSIFIED DRUG; VISMODEGIB; WNT PROTEIN;

ACUTE GRANULOCYTIC LEUKEMIA; BACKACHE; BASAL CELL CARCINOMA; BRAIN TUMOR; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER RADIOTHERAPY; CANCER RESISTANCE; CANCER STEM CELL; CELL LINEAGE; CELL MEMBRANE POTENTIAL; CELL PROLIFERATION; CELL RENEWAL; CELL SUBPOPULATION; CELL VIABILITY; CLINICAL TRIAL; COLORECTAL CANCER; CYTOLOGY; DYSPNEA; EMBRYO DEVELOPMENT; FATIGUE; GLIOBLASTOMA; HEAD AND NECK CARCINOMA; HUMAN; LUNG CANCER; LUNG NON SMALL CELL CANCER; MEDULLOBLASTOMA; MELANOMA; NONHUMAN; PATHOPHYSIOLOGY; RADIOSENSITIVITY; REVIEW; SOLID TUMOR; SQUAMOUS CELL CARCINOMA; TOXIC EPIDERMAL NECROLYSIS;

ANIMALS; CELL TRANSFORMATION, NEOPLASTIC; HUMANS; NEOPLASMS; NEOPLASTIC STEM CELLS;

EID: 79957457311     PISSN: 0378584X     EISSN: 14230240     Source Type: Journal    
DOI: 10.1159/000327815     Document Type: Review

References (70)

1. Reya T, Morrison SJ, Clarke MF, Weissman IL: Stem cells, cancer, and cancer stem cells. Nature 2001;414:105-111. (Pubitemid 33041634)
2. Clarke MF, Dick JE, Dirks P, Eaves C, Jamieson CH, Jones DL, Visvader IL, Weissman IL, Wahl GM: Cancer stem cells - perspectives on current status and future directions: AACR workshop on cancer stem cells. Cancer Res 2006;66:9339-9344. (Pubitemid 44623625)
3. Heppner GH: Tumor heterogeneity. Cancer Res 1984;44:2259-2265. (Pubitemid 14110633)
4. Dalerba P, Cho RW, Clarke MF: Cancer stem cells: models and concepts. Annu Rev Med 2007;58:267-284. (Pubitemid 46706514)
5. Visvader JE, Lindeman GJ: Cancer stem cells in solid tumours: accumulating evidence and unresolved questions. Nat Rev Cancer 2008;8:755-768.
6. Bonnet D, Dick JE: Human acute myeloid leukemia is organized as hierachy that originates from a primitve hematopoietic cell. Nat Med 1997;3:730-737. (Pubitemid 27298715)
7. Al-Hajj M, Wicha M, Benito-Hernandez A, Morrison S, Clarke M: Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci USA 2003;100:3983-3988. (Pubitemid 36418143)
8. Er O: Cancer stem cells in solid tumors. Onkologie 2009;32:605-609.
9. Collins AT, Berry PA, Hyde C, Stower M, Maitland N: Prospective identification of tumorigenic prostate cancer stem cells. Cancer Res 2005;65:10946-10951. (Pubitemid 41713363)
10. Gallantin W, Weissmann I, Butcher E: A cell surface molecule involved in organ specific homing of lymphocytes. Nature 1983;304:30-34. (Pubitemid 13063101)
11. Marhaba R, Klingbeil P, Nuebel T, Nazarenko I, Buechler MW, Zoeller M: CD44 and EpCAM: cancer-initiating cell markers. Curr Mol Med 2008;8:784-804.
12. Prince ME, Sivanandan R, Kaczorowski A, Wolf GT, Kaplan MJ, Dalerba P, Weissman IL, Clarke MF, Ailles LE: Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma. Proc Natl Acad Sci USA 2007;104:973-978. (Pubitemid 46154721)
13. Li CW, Heidt D, Dalerba P, Burant C, Zhang L, Adsay V, Wicha MS, Clarke MF, Simeone DM: Identification of pancreatic cancer stem cells. Cancer Res 2007;67:1030-1037.
14. Dalerba P, Dylla SJ, Park I, Liu R, Wang X, Cho RW, Hoey T, Gurney A, Huang EH, Simeone DM, Shelton AA, Parmiani G, Castelli Ch, Clarke MF: Phenotypic characterization of human colorectal cancer stem cells. Proc Natl Acad Sci USA 2007;104:10158-10163. (Pubitemid 47175279)
15. Ponta H, Sherman L, Herrlich P: CD44: from adhesion molecules to signaling regulators. Nat Rev Mol Cell Biol 2003;4:33-45. (Pubitemid 36077255)
16. Ruiz P, Schwärzler C, Günthert U: CD44 isoforms during differentiation. BioEssays 1995;17:17-24.
17. Orian-Rousseau V: CD44, a therapeutic target for metastasising tumours. Eur J Cancer 2010;46:1271-1277.
18. Du L, Wang H, He L, Zhang J, Ni B, Wang X, Hoey T, Gurney A, Huang EH, Simeone DM, Shelton AA, Parmiani G, Castelli Ch, Clarke MF: CD44 is of functional importance for colorectal cancer stem cells. Hum Cancer Biol 2008;14:6751-6760.
19. Riechelmann H, Sauter A, Golze W, Hanft G, Schroen C, Hoermann K, Erhardt T, Gronau S: Phase I trial with the mertansine in head and neck squamous cell carcinoma. Oral Oncol 2008;44:823-829.
20. Mizrak D, Brittan M, Alison MR: CD133: molecule of the moment. J Pathol 2008;214:3-9.
21. Hilbe W, Dirnhofer S, Oberwasserlechne F, Schmid T, Gunsilius E, Hilbe G, Wöll E, Kähler CM: CD133 positive endothelial progenitor cells contribute to the tumour vasculature in non-small cell lung cancer. J Clin Pathol 2004;57:965-969. (Pubitemid 39208249)
22. Corbeil D, Marzesco A, Fargeas CA, Huttner WB: Prominin-1 a distinct cholesterol-binding membrane protein and the organization of the apical plasma membrane of epithelial cells. Subcell Biochem 2010;51:399-423.
23. Bauer N, Fonseca A, Florek M, Freund D, Jaszai J, Bornhauser M, Fargeas CA, Corbeil D: New insights into cell biology of hematopoietic progenitors by studying prominin-1 (CD133). Cells Tissues Organs 2008;188:127-138. (Pubitemid 351962236)
24. Bidlingmaier S, Zhu X, Liu B: The utility and limitations of glycosylated human CD133 epitopes in defining cancer stem cells. J Mol Med 2008;86: 1025-1032.
25. Eramo A, Lotti F, Sette G, Pilozzi E, Biffoni M, Di Virgilio A, Conticello C, Ruco L, Peschle C, De Maria R: Identification and expansion of the tumorigenic lung cancer stem cell population. Cell Death Differ 2008;15:504-514. (Pubitemid 351267301)
26. Hermann PC, Huber S, Herrler T, Aicher A, Ellwart J, Guba M, Bruns CJ, Heeschen C: Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer. Cell Stem Cell 2007;1:313-323. (Pubitemid 47355323)
27. Brien CA, Pollett A, Gallinger S, Dick JE: A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature 2007;445:106-110. (Pubitemid 46067310)
28. Ma S, Chan K, Hu L, Lee T, Wo J, Ng I, Zheng BJ, Guan XY: Identification and characterization of tumorigenic liver cancer stem/progenitor cells. Gastroenterology 2007;132:2542-2556. (Pubitemid 46890873)
29. Singh S, Hawkins C, Clarke I, Squire J, Bayani J, Hide T, Henkelman RM, Cusimano MD, Dirks PB: Identification of human brain tumour initiating cells. Nature 2004;432:396-401. (Pubitemid 39551674)
30. Vlashi E, Kim K, Lagadec C, Donna LD, Mcdonald JT, Eghbali M, Sayre JW, Stefani E, Mcbride W, Pajonk F: In vivo imaging, tracking, and targeting of cancer stem cells. J Natl Cancer Inst 2009;101:350-359.
31. Li SC, May L, Tachiki L, Luo J, Dethlefs BA, Chen Z, Loudon GW: A biological global positioning system: considerations for tracking stem cell behaviors in the whole body. Stem Cell Rev 2010;6:317-333.
32. Frangioni J, Hajjar R: In vivo tracking of stem cells for clinical trials in cardiovascular disease. Circulation 2004;110:3378-3383. (Pubitemid 39557503)
33. Lin EH, Jiang Y, Deng Y, Lapsiwala R, Lin T, Blau C: Cancer stem cells, endothelial progenitors, and mesenchymal stem cells: 'Seed and Soil' theory revisited. Gastrointest Cancer Res 2008;2:169-174.
34. Bertolini G, Roz L, Perego P, Tortoreto M, Fontanella E, Gatti L, Pratesi G, Fabbri A, Andriani F, Tinelli S, Roz E, Caserini R, Lo Vullo S, Camerini T, Mariani L, Delia D, Calabro E, Pastorino U, Sozzi G: Highly tumorigenic lung cancer CD133+ cells display stem-like features and are spared by cisplatin treatment. Proc Natl Acad Sci USA 2009;106:16281-16286.
35. Kelly PN, Dakic A, Adamas J, Nutt S, Strasser A: Tumor growth need not be driven by rare cancer stem cells. Science 2007;317:337. (Pubitemid 47106366)
36. Peacock CD, Watkins DN: Cancer stem cells and the ontogeny of lung cancer. J Clin Oncol 2008;26: 2883-2889.
37. Cerdan C, Bhatia M: Novel roles for Notch, Wnt and Hedgehog in hematopoiesis derived from human pluripotent stem cells. Int J Dev Biol 2010; 54:955-963.
38. Giles RH, Es JH, Clevers H: Caught up in a Wnt storm: Wnt signaling in cancer. Biochim Biophys Acta 2003;1653:1-24. (Pubitemid 36627817)
39. Evangelista M, Tian H, Sauvage FJ: The Hedgehog signaling pathway in cancer. Clin Cancer Res 2006;12:5924-5928. (Pubitemid 44703749)
40. Leong KG, Karsan A: Recent insights into the role of Notch signaling in tumorigenesis. Cancer Res 2006;107:2223-2233. (Pubitemid 43345539)
41. Teng Y, Wang X, Wang Y, Ma D: Wnt/b-catenin signaling regulates cancer stem cells in lung cancer A549 cells. Biochem Biophys Res Commun 2010;392:373-379.
42. Liu S, Dontu G, Mantle ID, Patel S, Ahn N, Jackson KW, Suri P, Wicha MS: Hedgehog signaling and Bmi-1 regulate self-renewal of normal and malignant human mammary stem cells. Cancer Res 2006;66:6063-6071.
43. Yuan Z, Goetz J, Singh S, Ogden S, Petty W, Black C, Memoli VA, Dmitrovsky E, Robbins DJ: Frequent requirement of Hedgehog signaling in nonsmall cell lung carcinoma. Oncogene 2007;26:1046-1055.
44. Hoey T, Yen W, Axelrod F, Basi J, Donigian L, Dylla S, Fitch-Bruhns M, Lazetic S, Park IK, Sato A, Styal S, Wang X, Clarke MF, Lewicki J, Gurney A: DLL4 blockade inhibits tumor growth and reduces tumor-initiating cell frequency. Cell Stem Cell 2009;5:168-177.
45. Alison MR, Lim S, Nicholoson L: Cancer stem cells: problems for therapy? J Pathol 2010;223:147-161.
46. Schatton T, Murphy GF, Frank NY, Yamaura K, Waaga-Gasser AM, Gasser M, Zhan Q, Jordan S, Duncan LM, Weishaupt C, Fuhlbrigge RC, Kupper TS, Sayegh MH, Frank MH: Identification of cells initiating human melanomas. Nature 2008;451:345-349.
47. Huang Y: Membrane transporters and channels: role of the transportome in cancer chemosensitivity and chemoresistance. Cancer Res 2004;64:4294-4301. (Pubitemid 38802436)
48. Deonarain MP, Kousparou CA, Epenetos AA: Antibodies targeting cancer stem cells: a new paradigm in immunotherapy? MAbs 2009;1:12-25.
49. Gupta PB, Onder TT, Jiang G, Tao K, Kuperwasser C, Weinberg RA, Lander ES: Identification of selective inhibitors of cancer stem cells by high-throughput screening. Cell 2009;138:645-659.
50. Mahindroo N, Punchihewa C, Fujii N: Hegehhog- Gli signaling pathway inhibitors as anticancer agents. J Med Chem 2010;52:3829-3845.
51. Von Hoff D, LoRusso P, Rudin C, Reddy J, Yauch R, Tibes R, Weiss GJ, Borad MJ, Hann CL, Brahmer JR, Mackey HM, Lum BL, Darbonne WC, Marsters JC Jr, de Sauvage FJ, Low JA: Inhibition of the Hedgehog pathway in advanced basal-cell carcinoma. N Engl J Med 2009;361:1164-1172.
52. Rudin C, Hann C, Laterra J, Yauch R, Callahan C, Fu L, Holcomb T, Stinson J, Gould SE, Coleman B, LoRusso PM, Von Hoff DD, de Sauvage FJ, Low JA: Treatment of medulloblastoma with Hedgehog pathway inhibitor GDC-0449. N Engl J Med 2009;361:1173-1178.
53. Fan X, Khaki L, Zhu T, Soules M, Talsma C, Gul N, Koh C, Zhang J, Li YM, Maciaczyk J, Nikkhah G, Dimeco F, Piccirillo S, Vescovi AL, Eberhart CG: Notch pathway blockade depletes CD133-positive glioblastoma cells and inhibits growth of tumor neurospheres and xenografts. Stem Cells 2010;28:5-16.
54. Moffitt H; Lee Cancer Center and Research Institute, National Cancer Institute: A phase 2 open-label study of RO4929097 in metastatic colorectal cancer. http://clinicaltrials.gov/ct2/show/study/ NCT01116687?term = secretase+inhibitor+phase+2 and rank = 6, 2010.
55. Ahn S, Joyner A: In vivo analysis of quiescent adult neural stem cells responding to Sonic hedgehog. Nature 2005;437:894-897. (Pubitemid 41486765)
56. Watkins D, Berman D, Burkholder S, Wang B, Beachy P, Baylin S: Hedgehog signalling within airway epithelial progenitors and in small cell lung cancer. Nature 2003;422:313-317. (Pubitemid 36378358)
57. St-Jacques B, Hammerschmidt M, McMahon A: Indian hedgehog signaling regulates proliferation and differentaton of chondrocytes and is essential for bone formation. Genes Dev 1999;13:2072-2086. (Pubitemid 29407348)
58. Katoh Y, Katoh M: Hedgehog signaling pathway and gastrointestinal stem cell signaling network. Int J Mol Med 2006;18:1019-1023.
59. Kimura H, Ng JM, Curran T: Transient inhibition of the Hedgehog pathway in young mice causes permanent defects in bone structure. Cancer Cell 2008;13:249-260. (Pubitemid 351324879)
60. Low JA, Sauvage FJ: Clinical experience with Hedgehog pathway inhibitors. J Clin Oncol 2010; 28:5321-5326.
61. Phng L, Gerhardt H: Angiogenesis: a team effort coordinated by Notch. Dev Cell 2009;16:196-208.
62. Tien A, Rajan A, Bellen HJ: A Notch updated. Cell 2009;184:621-629.
63. Blazek ER, Foutch J, Makl G: Daoy medulloblastoma cells that express CD133 are radioresistant relative to CD133- cells, and the CD133+ sector is enlarged by hypoxia. Int J Radiat Oncol Biol Phys 2007;67:1-5. (Pubitemid 44959518)
64. Bao S, Wu Q, McLendon RE, Hao Y, Shi Q, Hjelmeland A, Dewhirst MW, Bigner DD, Rich JN: Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature 2006;444:756-760. (Pubitemid 44949604)
65. De Jong M, Pramana J, Lacko M, Peutz-Kootstra C, De-Jong J, Takes R: Prediction of local recurrence after radiotherapy in head and neck cancer by expression profiling. Radiother Oncol 2009;90:62.
66. Phillips TM, Mcbride WH, Pajonk F: The response of CD24-/low/CD44+ breast cancer-initiating cells to radiation. J Natl Cancer Inst 2006;98:1777-1785. (Pubitemid 46017929)
67. Rosen JM, Jordan CT: The increasing complexity of the cancer stem cell paradigm. Science 2009;324:1670-1673.
68. Quintana E, Shackleton M, Sabel MS, Fullen DR, Johnson TM, Morrison SJ: Efficient tumour formation by single human melanoma cells. Nature 2008;456:593-599.
69. Shmelkov SV, Butler JM, Hooper AT, Hormigo A, Kushner J, Milde T, St Clair R, Baljevic M, White I, Jin DK, Chadburn A, Murphy AJ, Valenzuela DM, Gale NW, Thurston G, Yancopoulos GD, D'Angelica M, Kemeny N, Lyden D, Rafii S: CD133 expression is not restricted to stem cells, and both CD133+ and CD133- metastatic colon cancer cells initiate tumors. J Clin Invest 2008; 118:2111-2120. (Pubitemid 351872330)
70. Jones RJ: Controversies in cancer stem cells. J Mol Med 2009;87:1077-1078.